Evaluating the impact of universal Lynch syndrome screening in a publicly funded healthcare system

ConclusionThe implementation of universal screening in a publicly funded system will increase efficiency in detecting patients with LS. The resources available for genetic testing and counseling may be more limited in public systems, thus inclusion of secondary screening withBRAF andMLH1 promoter hypermethylation testing is key to further optimizing efficiency.

Source: Cancer Medicine - July 22, 2020 Category: Cancer & Oncology Authors: Petra W. C. Lee, Angela C. Bedard, Setareh Samimi, Vivienne K. Beard, Quan Hong, James E. J. Bedard, Blake Gilks, David F. Schaeffer, Robert Wolber, Janice S. Kwon, Howard J. Lim, Sophie Sun, Kasmintan A. Schrader Tags: ORIGINAL RESEARCH Source Type: research